You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Population-Based Analysis of Meningococcal Disease Mortality in the United States: 19902002

Sharip, Akbar MD, MPH*; Sorvillo, Frank PhD*†; Redelings, Matthew D. MPH*; Mascola, Laurene MD, MPH*; Wise, Matthew MPH*†; Nguyen, Dao M. MD*

Pediatric Infectious Disease Journal:
doi: 10.1097/01.inf.0000202065.03366.0c
Original Studies
Abstract

Background: Neisseria meningitidis is a leading cause of bacterial meningitis and septicemia in the United States. Approximately 10–15% of meningococcal patients died despite antimicrobial therapies.

Methods: We used vital records to assess meningococcal disease mortality in the United States during 1990–2002. Meningococcal cases were defined as reported deaths with recorded International Classification of Diseases, 9th revision (ICD-9) codes 036.0–036.9 or ICD-10 codes A39.0–A39.9. Denominator data were obtained from population estimates published by the U.S. Census Bureau. We analyzed the effects of age, sex, race/ethnicity and season of the year on meningococcal disease mortality.

Results: We identified 3335 meningococcal deaths. Both the crude and age-adjusted mortality rates were 0.10 death per 100,000 population per year (95% confidence interval, 0.09–0.10). Fifty-eight percent of deaths occurred among persons younger than 25 years old. Mortality was elevated in infants, young adults (15–24 years old), and older adults (older than 74 years old). Mortality rates in African-Americans were 1.45 and 3.32 times higher than mortality rates in whites and Asians/Pacific Islanders, respectively. Mortality caused by meningococcal disease rose in winter months and declined during the summer. Observed mortality rates increased from 1990 to 1997 and decreased from 1997 to 2002.

Conclusions: Meningococcal disease continues to be an important, vaccine-preventable cause of death in the United States. Vaccination and other disease prevention efforts should be augmented for higher risk groups. Meningococcal mortality data can be used to assess the effectiveness of these efforts.

Author Information

From the *Los Angeles County Department of Health Services and the †Department of Epidemiology, University of California Los Angeles, School of Public Health, Los Angeles, CA

Accepted for publication October 28, 2005.

Supported by the Los Angeles County Department of Health Services.

Address for reprints: Akbar Sharip, Bioterrorism Preparedness Unit, Acute Communicable Disease Program, Los Angeles Department of Health Services, 313 N. Figueroa Street, No. 211, Los Angeles, CA 90012. Fax 213-580-0194; E-mail asharip@ladhs.org.

© 2006 Lippincott Williams & Wilkins, Inc.